ZKY 019
Alternative Names: ZKY-019Latest Information Update: 01 Feb 2023
Price :
$50 *
At a glance
- Originator China Ophthalmology Focus
- Developer Zhaoke Ophthalmology Limited
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preregistration Female genital diseases
Most Recent Events
- 01 Feb 2023 ZKY 019 is still in preregistration phase for Female genital diseases in China (Lee's Pharmaceutical pipeline, February 2023)
- 10 Dec 2020 Preregistration for Female genital diseases in China (unspecified route) prior to December 2020 (Lee's Pharmaceutical pipeline, December 2020)